About Us

Group Photo Parkinson's Disease International Conference

Vision

The Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease (APPD) has been established by a generous donation from the Aufzien Family to promote and enhance research towards better treatment and prevention of Parkinson's Disease.

 

Mission

The APPD is an academic Center at The Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University, which serves as a hub for innovative translational research in Parkinson's Disease. The center has a grant program and educational activities to support cutting-edge research towards better treatment and prevention, or slowing down of Parkinson's Disease progression. The Center holds monthly seminars, annual international symposiums and active student exchange programs. 

 

APPD Structure

 

 

 

‚Äč

 

 

 

Prof. Nir Giladi

 

 

Nir Giladi, M.D., is a renowned leader in the field of movement disorders, full professor at the Sackler Faculty of Medicine at Tel Aviv University and chairman of the Neurological Institute at the Tel Aviv Sourasky Medical Center.

His research interests are in the field of gait, falls, cognition and genetics in Parkinson's Disease. Over the past decade, Prof. Giladi has devoted much of his time to research regarding the prodromal stage of Parkinson's Disease, focusing on biological markers of early detection and predicting the conversion from a subject at risk to a patient with Parkinson's Disease.

 

Prof. Karen B. Avraham

 

 

Karen B. Avraham, Ph.D., is Vice Dean at the Sackler Faculty of Medicine and holds the Drs. Sarah and Felix Dumont Chair for Research of Hearing Disorders. She performs research on the genomics of deafness at the Department of Human Molecular Genetics and Biochemistry and is a member of the Sagol School of Neuroscience and the Safra Center for Bioinformatics. Dr. Avraham was awarded the Sir Bernard Katz Prize (Humboldt Foundation, Germany), the Bruno Memorial Prize (Rothschild Foundation), the TEVA Prize for Groundbreaking Research in Rare Diseases, the Teva Founders Prize on Breathroughs and most recently, the Beutler Research Program of Excellence in Genomic Medicine. Her team's grant support is from the National Institute of Health (NIH), Israel Science Foundation (ISF), Israel Precision Medicine Partnership (IPMP) Program, German-Israel Research Foundation (GIF), and Beutler Research Program of Excellence in Genomic Medicine.

 

Personal and company donations will all be devoted to further support research in the treatment and prevention of Parkinson's Disease.

 

To contribute, please contact us.

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive